You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis

    SBC: Sanguine Diagnostics And Therapeutics, Inc.            Topic: 103

    ABSTRACT Pancreatic cancer PC is an extremely aggressive malignancy with one of the worst prognoses of all cancers with a median survival of less than one year and an overall year survival of andlt With marked resistance to chemo and radiotherapies surgery is the only curative option In patients with localized disease and no lymph node or extra pancreatic metastases complete surgical ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. UCDS Unsteady Reaction Model

    SBC: GLOYER-TAYLOR LABORATORIES INC            Topic: MDA09T009

    The UCDS process uses a rigorous theoretical model to understand the dynamics of combustion instability. In addition to predicting the amplitude of pressure oscillations, UCDS provides clear insight into why a propulsion device oscillates. To enhance and optimize UCDS for missile defense applications, GTL proposes to refine the UCDS unsteady combustion model to capture the special features of mon ...

    STTR Phase I 2010 Department of DefenseMissile Defense Agency
  3. UCDS Unsteady Reaction Model

    SBC: GLOYER-TAYLOR LABORATORIES INC            Topic: MDA09T009

    The overall objective of the Phase II effort is to enhance the capability of the UCDS process to simulate and predict the characteristics of combustion instability in propulsion devices, specifically focusing on the propulsion devices used in missile defense applications. GTL shall apply proven techniques to rigorously develop a reaction wave model that is consistent with the rest of the UCDS pro ...

    STTR Phase II 2012 Department of DefenseMissile Defense Agency
  4. The Molecular Culture

    SBC: TRANSGENOMIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In the clinical setting, molecular microbiologic detection methods have classically focused on a single microorganism or a small group of microorganisms. Broad range molecular detection of bacteria in clinical specimens is an approach that parallels a conventional culture-based approach, may be more rapid, and offers the possibility of identifying so-called "n ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. TGF-beta for Pleurodesis

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Approximately 50,000 cancer patients a year have recurrent fluid accumulation in the space between their chest wall and lung. This condition is called malignant pleural effusion (MPE). This fluid impairs breathing and worsens the quality of life in these patients. The current treatments are not ideal and include removing the fluid by repetitive needle aspiratio ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Temperature-Tolerant COLD-PCR enables mutation-enriched targeted re-sequencing

    SBC: TRANSGENOMIC, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Cancers develop from the life-long accumulation of critical somatic mutations due to DNA-damaging agents that lead to cells transforming into tumor-forming cells. These low-level tumor-associated somatic DNA mutations can have profound implications for development of metastasis, prognosis, choice of treatment, follow-up or early cancer detection. Unless they ar ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Targeting DNA damage response pathways for the treatment of advanced lung cancer

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: NIEHS

    DESCRIPTION (provided by applicant): There is an urgent, unmet need for novel therapeutic approaches that are efficacious against lung cancer. Ranking first among cancer deaths in the U.S., this disease has 5-year relative survival rates of lt20%. Most lung cancers are non-small cell (NSCLC, 85% of cases). Curative surgery is not an option for the 80% of NSCLC patients who present with advanced s ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Targeted Therapies for the Treatment of GI-ARS Diarrhea

    SBC: Rxbio, Inc.            Topic: 300

    The US population at large, and particularly military personnel and first responders, are at risk of radiation exposure due to the explosion of a nuclear device, a nuclear reactor accident, and the threat of radiation terror- ism. There is no radiation medical countermeasure (RCM) drug approved by the FDA that meets the criterion of a gastrointestinal (GI) radiomitigator – an agent which mitigat ...

    STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  9. Targeted Oncolytic VSV as a Prostate Cancer Therapy

    SBC: ONCTERNAL THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the most common malignancy in men in the United States and the second leading cause of cancer mortality. Unfortunately there is no cure by standard medical treatment. Therefore, novel treatments for this devastating, common disease are desperately needed. Recent progress in the development of targeted oncolytic viral vectors offer a new strat ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  10. SUPERCONDUCTING MAGNET FOR MICROCOIL NMR

    SBC: American Magnetics, Inc.            Topic: N/A

    DESCRIPTION (Verbatim from the Applicant's Abstract): The specific aims of this Phase I STTR project, proposed by the American Magnetics, Inc. in partnership with the MIT Francis Bitter Magnet Laboratory, are: 1) experimental demonstration of feasibility of innovative design and operation features applicable to NMR Nb3Sn-magnet/cryocooler systems; and 2) co ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government